Showing 1 - 5 results of 5 for search 'Ana Graf', query time: 0.01s Refine Results
  1. 1
    Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease

    Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease by Ronald C. Petersen, Ana Graf, Alexandra S. Atkins, Miroslaw Brys, Jennifer Murphy, David S. Miller, Larisa Reyderman, Eric Siemers, Janice Smith, Maria C. Carrillo, Christopher J. Weber

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations: Proceedings from the Alzheimer's Association Research Roundtable (AARR) Fall 2021 meeting

    Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations: Proceedings from the Alzheimer's Association Research Roundta... by Ronald C. Petersen, Ana Graf, Chris Brady, Susan De Santi, Hana Florian, Jaren Landen, Mike Pontecorvo, Christopher Randolph, Kaycee Sink, Maria Carrillo, Christopher J. Weber

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practice

    Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practice by Clifford R. Jack, Ana Graf, Samantha C. Burnham, Erin G Doty, Hans J. Moebius, Philip Montenigro, Eric Siemers, Kaycee M. Sink, Leslie M. Shaw, Charlotte Thim Hansen, Kristin R. Wildsmith, Simin Mahinrad, Maria C. Carrillo, Christopher J. Weber

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease

    The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease by Cristina Lopez Lopez, Pierre N. Tariot, Angelika Caputo, Jessica B. Langbaum, Fonda Liu, Marie‐Emmanuelle Riviere, Carolyn Langlois, Marie‐Laure Rouzade‐Dominguez, Martin Zalesak, Suzanne Hendrix, Ronald G. Thomas, Vissia Viglietta, Rob Lenz, J. Michael Ryan, Ana Graf, Eric M. Reiman

    Published 2019-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease

    The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease by Ulf Neumann, Mike Ufer, Laura H Jacobson, Marie‐Laure Rouzade‐Dominguez, Gunilla Huledal, Carine Kolly, Rainer M Lüönd, Rainer Machauer, Siem J Veenstra, Konstanze Hurth, Heinrich Rueeger, Marina Tintelnot‐Blomley, Matthias Staufenbiel, Derya R Shimshek, Ludovic Perrot, Wilfried Frieauff, Valerie Dubost, Hilmar Schiller, Barbara Vogg, Karen Beltz, Alexandre Avrameas, Sandrine Kretz, Nicole Pezous, Jean‐Michel Rondeau, Nicolau Beckmann, Andreas Hartmann, Stefan Vormfelde, Olivier J David, Bruno Galli, Rita Ramos, Ana Graf, Cristina Lopez Lopez

    Published 2018-09-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: